4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000064
Chief Scientific Officer acquired 13,629 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kishimoto Takashi Kei · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-07 | Exercise or conversion : show line 1 in the form | +13,629 | $2.77 | $37,752 | 177,778 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-07 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −13,629 | 0 | D |
Loading xslF345X03/wf-form4_162076464438216.xml…